Trial Profile
To evaluate safety and efficacy of Ivabradine in pulmonary arterial hypertension patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 15 Jul 2015 New trial record